11:09:37 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-08-29 Kvartalsrapport 2024-Q2
2024-05-15 Årsstämma 2024
2024-04-25 Bokslutskommuniké 2023
2023-10-11 Extra Bolagsstämma 2023
2023-08-31 Kvartalsrapport 2023-Q2
2023-05-30 Ordinarie utdelning BRAINP 0.00 DKK
2023-05-26 Årsstämma 2023
2023-04-28 Bokslutskommuniké 2022
2022-09-29 Kvartalsrapport 2022-Q2
2022-09-02 Extra Bolagsstämma 2022
2022-05-19 Ordinarie utdelning BRAINP 0.00 DKK
2022-05-18 Årsstämma 2022
2022-04-29 Bokslutskommuniké 2021

Beskrivning

LandDanmark
ListaFirst North Denmark
SektorHälsovård
IndustriVård & Omsorg
Brain+ är verksamma inom läkemedelsbranschen. Bolaget är specialiserade inom forskning och utveckling för behandling av demens och alzheimers. Produktportföljen inkluderar exempelvis kognitiv stimuleringsterapi. Utöver huvudverksamheten erbjuds även service och tillhörande kringtjänster. Verksamheten drivs med störst närvaro inom Europa.
2023-08-22 08:30:00

Copenhagen, Denmark, May 22, 2023 - Brain+ A/S (Nasdaq First North: BRAINP)

On Friday 01 September 2023 at 16:00 CEST, Brain+ will host an online Investor Update. The Investor Update will start with a presentation from the CEO, Kim Baden-Kristensen followed by a Q&A session where the CEO will answer questions from investors.

Brain+ invites all interested, both current investors and potential investors to participate in this event, ask questions directly before the event starts, and upvote those questions you would like addressed. The Q&A is already open, meaning that you can already now submit your questions and vote for the best questions submitted by other investors.

Brain+ will address as many questions as possible, and focus on those questions most wanted by investors.The web conference will be held in English. Please register, submit questions now or during the live presentation, and vote for the best questions at the following link:

https://stokk.io/app/event/94/h1-2023-presentation/

Contact Information

CEO and Co-founder: Kim Baden-Kristensen, + 45 31393317 (SMS), kim@brain-plus.com

Brain+ mission: Bringing effective digitally-delivered dementia therapies to those in need, serving a million people with dementia, care-givers and clinicians by 2030.